China Grapples To Get A Handle On Reporting Mechanisms For Adverse Drug Reactions
This article was originally published in The Pink Sheet Daily
Executive Summary
As far back as 2004, the Measures on Administration of Reporting and Monitoring of Adverse Drug Reactions were promulgated. By 2007, there were 400 cases per million people reported.
You may also be interested in...
Safety Of Traditional Chinese Medicine Injections Questioned Following Three Deaths
SHANGHAI - Three deaths caused by adverse drug reactions allegedly linked to use of herbal injection Shuanghuanglian have raised wider concerns over the safety of herbal injections in China
China’s 2009 Regulatory Changes Will Affect Makers of Drugs, APIs and Devices
BEIJING - An array of regulatory and legal changes covering pharmaceuticals and medical devices in China is likely to be launched or broadened this year, including new GMP guidelines, as the country aims to upgrade supervision of the entire health care sector, according to a leading Chinese lawyer in the area of life sciences-related issues and legislation
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.